April 16, 2014 12:40 AM ET

Capital Markets

Company Overview of Index Ventures

Executive Profile

Rémy Luthringer Ph.D.

Venture Partner, Index Ventures
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


Mr. Rémy Luthringer, Ph.D. is a Venture Partner at Index Ventures. Dr. Luthringer focuses on investments in Life sciences, Healthcare Infrastructure in Switzerland, France, and United Kingdom. He served as the Chief Medical Officer of Index Ventures since 2010. Prior to joining Index Ventures in 2010, he served as the Chief Executive Officer of one of the research institutes in neurosciences. He served as the Chief Executive Officer of Groupe FORENAP and FORENAP Pharma ...

Corporate Headquarters

2, rue de Jargonnant
Geneva, Geneva 1207


Phone: 41 22 737 00 00
Fax: 41 22 737 00 99

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Index Ventures, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.